(Q82359377)
Statements
The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes (English)
Hajime Maeda
Akira Kubota
Yasushi Tanaka
Yasuo Terauchi
Ikuro Matsuba
ASSET-K Study group